Fifteen patients with colorectal cancer participated in semi-structured interviews, designed to get their opinions on the dissemination of information about dihydropyrimidine dehydrogenase (DPD) testing (31), that is done before delivery of treatment to reduce side effects. This evidence concerns the gene DPYD and colorectal cancer.